Colfosceril palmitate

Colfosceril palmitate
Clinical data
Trade names	Exosurf
Other names	[2-({[2,3-bis(hexadecanoyloxy)propyl] phosphonato}oxy)ethyl]trimethylazanium
AHFS/Drugs.com	International Drug Names
ATC code	R07AA01 (WHO) ;
Identifiers
	IUPAC name 2,3-di(hexadecanoyloxy)propyl 2-trimethylazaniumylethyl phosphate;
CAS Number	63-89-8 ;
PubChem CID	6138;
ChemSpider	5908 ;
UNII	319X2NFW0A;
KEGG	D03585 ;
ChEMBL	ChEMBL1200737 ;
CompTox Dashboard (EPA)	DTXSID5046720 ;
ECHA InfoCard	100.000.516
Chemical and physical data
Formula	C40H80NO8P
Molar mass	734.053 g·mol−1
3D model (JSmol)	Interactive image;
	SMILES O=C(OCC(OC(=O)CCCCCCCCCCCCCCC)COP([O-])(=O)OCC[N+](C)(C)C)CCCCCCCCCCCCCCC;
	InChI InChI=1S/C40H80NO8P/c1-6-8-10-12-14-16-18-20-22-24-26-28-30-32-39(42)46-36-38(37-48-50(44,45)47-35-34-41(3,4)5)49-40(43)33-31-29-27-25-23-21-19-17-15-13-11-9-7-2/h38H,6-37H2,1-5H3 ; Key:KILNVBDSWZSGLL-UHFFFAOYSA-N ;
	(what is this?) (verify)

Colfosceril palmitate (trade name Exosurf) is a drug used as a pulmonary surfactant.^[1] It is a drug that is used in surfactant deficient conditions such as infant respiratory distress syndrome in newborns.

References

^ Rubin BK (1996). "Therapeutic aerosols and airway secretions". Journal of Aerosol Medicine. 9 (1): 123–30. doi:10.1089/jam.1996.9.123. PMID 10160202.

This drug article relating to the respiratory system is a stub. You can help Wikipedia by expanding it.